Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024
May 13, 2024 07:00 ET
|
Entera Bio Ltd.
JERUSALEM, May 13, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today...
US Digestive Health Expands Access to Advanced Gastroenterology Care Through its Partnership with Southwest Gastroenterology Associates (SWGA)
December 19, 2023 10:00 ET
|
US Digestive Health
EXTON, Pa., Dec. 19, 2023 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the largest gastroenterology practices in the United States, managed by US Digestive Health Management (USDHM), a...
US Digestive Health Announces Partnership with GI Specialists of Delaware
September 14, 2023 10:00 ET
|
US Digestive Health
EXTON, Pa., Sept. 14, 2023 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the largest gastroenterology (GI) practices in the United States, today announced its partnership with GI...
Rani Therapeutics’ Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference
June 21, 2023 08:00 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
US Digestive Health Announces Four New Providers to Its Gastroenterology Practice
June 13, 2023 11:00 ET
|
US Digestive Health
EXTON, Pa., June 13, 2023 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the largest gastroenterology (GI) practices in the nation, today announced the addition of four medical providers. ...
Right On Brands Inc Announces Reverse Split
December 27, 2022 08:00 ET
|
Right On Brands, Inc.
ROWLETT, TEXAS, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Right on Brands Inc (OTC Pink: RTON), a leader and innovator of HEMP DERIVED, and WELLNESS products announced today that its Board of Directors has...
Right On Brands Forms Endo Franchise Group Inc.
December 09, 2022 08:00 ET
|
Right On Brands, Inc.
Rowlett, TX, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer and developer of hemp derived products has filed Endo Franchise Group Inc with the...
Right On Brands files form 1-A REG A and Issues Corporate Update
October 24, 2022 12:24 ET
|
Right On Brands, Inc.
Rowlett, TX, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer and developer of hemp-based products, is pleased to announce that we have filed a...
Right On Brands Issues Corporate Update
August 24, 2022 08:00 ET
|
Right On Brands, Inc.
Rowlett, TX, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer and developer of hemp-based products, is pleased to announce the following updates....
Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at ENDO 2022, the Endocrine Society’s Annual Meeting
June 09, 2022 09:05 ET
|
Clarus Therapeutics Holdings, Inc.
JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions NORTHBROOK, Ill., June 09, 2022...